about
Bis-arylidene oxindoles as anti-breast-cancer agents acting via the estrogen receptor.Data for stable formulation of steroid hormone receptor-targeted liposomes for cancer therapeuticsNon-metastatic 2 (NME2)-mediated suppression of lung cancer metastasis involves transcriptional regulation of key cell adhesion factor vinculinQuantification of lipid modified estrogenic derivative (ESC8) in rat plasma by LC-MS: application to a pharmacokinetic study.N-end rule pathway inhibition assists colon tumor regression via necroptosis.Engineered reversal of drug resistance in cancer cells--metastases suppressor factors as change agents.Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive Tumors.Green Synthesis and Characterization of Monodispersed Gold Nanoparticles: Toxicity Study, Delivery of Doxorubicin and Its Bio-Distribution in Mouse Model.Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.Cationic lipid-conjugated dexamethasone as a selective antitumor agent.Cancer cell-selective promoter recognition accompanies antitumor effect by glucocorticoid receptor-targeted gold nanoparticle.Bis-arylidene oxindole-betulinic Acid conjugate: a fluorescent cancer cell detector with potent anticancer activityPolyketide Quinones Are Alternate Intermediate Electron Carriers during Mycobacterial Respiration in Oxygen-Deficient Niches.Mineralocorticoid receptor mediated liposomal delivery system for targeted induction of apoptosis in cancer cells.Development of new estradiol-cationic lipid hybrids: ten-carbon twin chain cationic lipid is a more suitable partner for estradiol to elicit better anticancer activity.Development and characterization of monomeric N-end rule inhibitors through in vitro model substrates.Estrogen Receptor-Mediated Liposomal Drug Delivery For Treating Melanoma.Combination of cationic dexamethasone derivative and STAT3 inhibitor (WP1066) for aggressive melanoma: a strategy for repurposing a phase I clinical trial drug.Cationic folate-mediated liposomal delivery of bis-arylidene oxindole induces efficient melanoma tumor regression.Glucocorticoid receptor-mediated delivery of nano gold-withaferin conjugates for reversal of epithelial-to-mesenchymal transition and tumor regression.α-Tocopherol-based cationic amphiphiles with a novel pH sensitive hybrid linker for gene delivery.α-Tocopherol-ascorbic acid hybrid antioxidant based cationic amphiphile for gene delivery: Design, synthesis and transfectionPhenazine-1-carboxamide functionalized mesoporous silica nanoparticles as antimicrobial coatings on silicone urethral cathetersCationic lipid-conjugated hydrocortisone as selective antitumor agentGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Development of Liposomal Formulation for Delivering Anticancer Drug to Breast Cancer Stem-Cell-Like Cells and its Pharmacokinetics in an Animal ModelTowards the diastereoselective synthesis of derivative of 11'-epi-brevipolide HExploring membrane permeability of Tomatidine to enhance lipid mediated nucleic acid transfectionsGreen Transfection: Cationic Lipid Nanocarrier System Derivatized from Vegetable Fat, Palmstearin Enhances Nucleic Acid TransfectionsEfficient anti-tumor nano-lipoplexes with unsaturated or saturated lipid induce differential genotoxic effects in miceEvaluation of the in vivo genotoxicity of liposomal formulation for delivering anticancer estrogenic derivative (ESC8) in a mouse modelN-end rule pathway inhibitor sensitizes cancer cells to antineoplastic agents by regulating XIAP and RAD21 protein expressionAmphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma
P50
Q30746277-5A0E5B21-F1B2-4EFB-84CE-14842E5E4359Q31061920-F6CA498E-ED3A-4878-A1B3-D6F274291231Q34313101-36BC4D9A-CCEC-4309-99E1-E2CC3EB0BB8AQ36053456-0BB1A741-DD1B-4350-9705-2D8356E9FC8AQ37165646-1C99C7F1-9C85-42AB-A2A6-D534BDECD2DDQ37518671-8A8A3337-8A81-415F-8C1B-F8014384F5BDQ37644744-B5277822-98D2-44A2-B035-02D833894F0DQ38853261-ECA8CC6E-1826-40D8-9B0B-5C5E4997CFC4Q38911811-2C9B7AB0-AA8D-4D5C-B846-32F626AC7C1FQ38978423-4B5B83E2-D599-4199-A46D-1044BB6C93BEQ38995380-0BDDD4CD-53AD-41F8-BFB8-B8095C254A22Q40753244-938A4B8C-2362-40E4-9674-9DACB11D3B41Q40903488-DD8472EC-91CE-4A5A-839D-77D613181092Q42817499-56B87AB3-9A93-49B1-A7B4-BE2E128E27C4Q42835432-D8F006AD-8759-48A0-9708-421A1B6B5F1CQ43996844-37D41F04-1838-4FAA-BE34-2ECD5B4093B2Q47835405-05E8A1E1-24CE-45A3-8FA1-F203F5D1ACBEQ48775208-64916D08-EB72-49C8-8AD1-62C7337EC539Q50886544-28A46533-26B9-415B-B51E-16C1638A580BQ51736337-534D31D3-04E6-4596-AE40-C3AE4309E4A5Q52603455-EF29C0F6-5EC1-41A6-93A0-3D1326F1588FQ57497814-7810B155-F458-405B-AF2B-7A75333F718EQ64106691-8874E840-14FD-413B-B720-58139FD4676DQ86958750-3BE1FAEF-3E98-4919-A106-57589B7CF912Q87139132-7E33C025-43AF-400D-AAB3-304DEFED7DB6Q87203393-FD0B6CA4-C195-412A-93FD-49DF9200E6A3Q87267009-9B08A7E8-E624-477B-928F-EB529134056FQ89103938-CB8F8169-15D3-4742-BCD6-D8504E6C6137Q90332602-A4CF0799-652E-48F0-A3E8-8F17BEF346B6Q91791751-9BC818A6-EE0A-415F-AF04-4DCEB17A2C38Q91810745-28AFC43C-467F-4B92-BCD1-933BF04B444FQ92585513-0FAF82EA-9A45-4D99-994B-D02AF9A42DD7Q93207321-C4632EB7-C29C-4A8E-95DD-51363441F085
P50
description
investigador
@es
researcher
@en
name
Rajkumar Banerjee
@en
type
label
Rajkumar Banerjee
@en
prefLabel
Rajkumar Banerjee
@en
P31
P496
0000-0003-2336-6294